Christopher B. Primiano

2018

In 2018, Christopher B. Primiano earned a total compensation of $1.5M as Executive Vice President, Chief Business Officer, General Counsel and Secretary at Karyopharm Therapeutics, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$204,020
Option Awards$902,913
Salary$404,000
Other$11,660
Total$1,522,593

Primiano received $902.9K in option awards, accounting for 59% of the total pay in 2018.

Primiano also received $204K in non-equity incentive plan, $404K in salary and $11.7K in other compensation.

Rankings

In 2018, Christopher B. Primiano's compensation ranked 7,090th out of 14,244 executives tracked by ExecPay. In other words, Primiano earned more than 50.2% of executives.

ClassificationRankingPercentile
All
7,090
out of 14,244
50th
Division
Manufacturing
2,725
out of 5,765
53rd
Major group
Chemicals And Allied Products
1,027
out of 2,128
52nd
Industry group
Drugs
866
out of 1,817
52nd
Industry
Pharmaceutical Preparations
676
out of 1,391
51st
Source: SEC filing on April 19, 2019.

Primiano's colleagues

We found four more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2018.

2018

Anand Varadan

Karyopharm Therapeutics

Executive Vice President, Chief Commercial Officer

2018

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2018

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2018

Michael MSM

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like